Q3 2024 |
106 |
$359M |
+$20.9M |
-$22.4M |
-$1.55M |
ORCL, ABBV, NEM, GS, PM
|
13F-HR |
11/6/2024, 08:00 AM |
Q2 2024 |
103 |
$336M |
+$10.3M |
-$10.6M |
-$285K |
ABBV, NEM, ORCL, GS, SLB
|
13F-HR |
8/5/2024, 03:57 PM |
Q1 2024 |
102 |
$332M |
+$14.6M |
-$8.17M |
+$6.43M |
ABBV, NEM, SLB, GS, ORCL
|
13F-HR |
4/26/2024, 12:18 PM |
Q4 2023 |
98 |
$310M |
+$26.8M |
-$18.7M |
+$8.09M |
ABBV, NEM, SLB, GS, PFE
|
13F-HR |
2/9/2024, 10:02 AM |
Q3 2023 |
99 |
$283M |
+$8.66M |
-$8.69M |
-$29.3K |
ABBV, SLB, CSCO, ORCL, CVX
|
13F-HR |
11/2/2023, 10:09 AM |
Q2 2023 |
101 |
$287M |
+$17.1M |
-$14.3M |
+$2.81M |
ABBV, ORCL, AAPL, SLB, HCA
|
13F-HR |
8/1/2023, 10:19 AM |
Q1 2023 |
100 |
$277M |
+$8.83M |
-$22.3M |
-$13.4M |
ABBV, XOM, SLB, GS, CSCO
|
13F-HR |
4/28/2023, 10:30 AM |
Q4 2022 |
101 |
$284M |
+$13.1M |
-$29.5M |
-$16.4M |
ABBV, SLB, XOM, GS, CVX
|
13F-HR |
2/9/2023, 10:00 AM |
Q3 2022 |
104 |
$264M |
+$12.9M |
-$6.56M |
+$6.3M |
ABBV, AAPL, SLB, XOM, GS
|
13F-HR |
11/7/2022, 10:16 AM |
Q2 2022 |
106 |
$282M |
+$24M |
-$18.4M |
+$5.61M |
ABBV, AAPL, SLB, GS, XOM
|
13F-HR |
8/5/2022, 11:59 AM |
Q1 2022 |
103 |
$320M |
+$41M |
-$26.1M |
+$14.9M |
ABBV, SLB, AAPL, GS, CSCO
|
13F-HR |
5/4/2022, 10:03 AM |
Q4 2021 |
100 |
$299M |
+$7.6M |
-$101M |
-$93.4M |
ABBV, FITB, AAPL, MS, GS
|
13F-HR |
2/11/2022, 02:13 PM |
Q3 2021 |
103 |
$367M |
+$7.7M |
-$59.9M |
-$52.3M |
FITB, MS, GS, ABBV, C
|
13F-HR |
11/12/2021, 09:04 AM |
Q2 2021 |
134 |
$429M |
+$21.1M |
-$11.8M |
+$9.33M |
AAPL, GS, SLB, FITB, MS
|
13F-HR |
8/12/2021, 01:56 PM |
Q1 2021 |
128 |
$396M |
+$46.2M |
-$25.9M |
+$20.2M |
AAPL, FITB, GS, ABBV, FHI
|
13F-HR |
5/6/2021, 03:18 PM |
Q4 2020 |
124 |
$336M |
+$17.5M |
-$31.7M |
-$14.1M |
AAPL, ABBV, MS, HCA, PARA
|
13F-HR |
2/10/2021, 08:00 AM |
Q3 2020 |
119 |
$296M |
+$22.2M |
-$4.69M |
+$17.6M |
AAPL, ABBV, QCOM, HCA, MS
|
13F-HR |
11/12/2020, 09:39 AM |
Q2 2020 |
117 |
$282M |
+$27.6M |
-$31.6M |
-$4.05M |
AAPL, ABBV, CSCO, MS, T
|
13F-HR |
8/11/2020, 08:08 AM |
Q1 2020 |
118 |
$236M |
+$20.7M |
-$37M |
-$16.3M |
AAPL, T, CSCO, GS, MSFT
|
13F-HR |
5/7/2020, 11:41 AM |
Q4 2019 |
128 |
$369M |
+$17.1M |
-$22.5M |
-$5.34M |
AAPL, FITB, C, T, GS
|
13F-HR |
2/12/2020, 04:08 PM |
Q3 2019 |
116 |
$351M |
+$31.8M |
-$27.9M |
+$3.88M |
FITB, CSCO, AAPL, C, T
|
13F-HR |
11/6/2019, 02:36 PM |
Q2 2019 |
108 |
$352M |
+$24.5M |
-$28.1M |
-$3.66M |
CSCO, FITB, AAL, RDSB, C
|
13F-HR |
8/12/2019, 09:22 AM |
Q1 2019 |
112 |
$343M |
+$15.1M |
-$24.8M |
-$9.68M |
CSCO, INTC, FITB, AAL, RDSB
|
13F-HR |
5/3/2019, 09:00 AM |
Q4 2018 |
112 |
$318M |
+$16.7M |
-$18.7M |
-$1.96M |
CSCO, INTC, AAL, SIX, RDSB
|
13F-HR |
2/8/2019, 09:12 AM |
Q3 2018 |
122 |
$386M |
+$9.42M |
-$35.6M |
-$26.2M |
CSCO, WY, INTC, AAL, AAPL
|
13F-HR |
11/9/2018, 09:40 AM |
Q2 2018 |
116 |
$399M |
+$18M |
-$61.4M |
-$43.4M |
WY, CSCO, INTC, RDSB, BP
|
13F-HR |
8/10/2018, 02:11 PM |
Q1 2018 |
117 |
$437M |
+$48.7M |
-$31.3M |
+$17.5M |
WY, CSCO, INTC, GS, AAL
|
13F-HR |
5/7/2018, 11:16 AM |
Q4 2017 |
117 |
$440M |
+$23.1M |
-$22.8M |
+$272K |
WY, CSCO, GS, AAL, C
|
13F-HR |
2/8/2018, 11:35 AM |
Q3 2017 |
102 |
$420M |
+$29.4M |
-$20.9M |
+$8.58M |
WY, C, CSCO, GS, AAL
|
13F-HR |
11/13/2017, 10:24 AM |
Q2 2017 |
105 |
$398M |
+$23M |
-$35.6M |
-$12.6M |
WY, C, CSCO, AAL, GS
|
13F-HR |
8/4/2017, 12:15 PM |
Q1 2017 |
110 |
$414M |
+$19.3M |
-$21M |
-$1.73M |
WY, CSCO, C, GS, AAL
|
13F-HR |
5/4/2017, 11:17 AM |
Q4 2016 |
108 |
$403M |
+$27.4M |
-$53.4M |
-$26M |
WY, CSCO, C, GS, AAL
|
13F-HR |
2/7/2017, 04:20 PM |
Q3 2016 |
105 |
$402M |
+$16.9M |
-$40M |
-$23.1M |
WY, CSCO, AAL, C, GM
|
13F-HR |
11/3/2016, 11:15 AM |
Q2 2016 |
105 |
$404M |
+$28.1M |
-$11.7M |
+$16.4M |
WY, CSCO, GE, C, AAL
|
13F-HR |
8/10/2016, 09:26 AM |
Q1 2016 |
105 |
$390M |
+$49M |
-$46.4M |
+$2.54M |
WY, CSCO, GE, GM, AAL
|
13F-HR |
5/10/2016, 09:31 AM |
Q4 2015 |
110 |
$386M |
+$37.3M |
-$161M |
-$124M |
AAL, GM, CSCO, GS, GE
|
13F-HR |
2/9/2016, 10:09 AM |
Q3 2015 |
108 |
$458M |
+$42.1M |
-$72.9M |
-$30.8M |
C, AAL, GM, MS, UAL
|
13F-HR |
10/30/2015, 12:34 PM |
Q2 2015 |
116 |
$543M |
+$43.2M |
-$34.7M |
+$8.54M |
AAL, C, MS, DHI, GM
|
13F-HR |
8/11/2015, 12:32 PM |
Q1 2015 |
116 |
$561M |
+$65.5M |
-$50.2M |
+$15.3M |
AAL, DHI, C, MS, UAL
|
13F-HR |
5/4/2015, 12:56 PM |
Q4 2014 |
116 |
$540M |
+$49M |
-$99.2M |
-$50.2M |
AAL, MS, KMI, C, DHI
|
13F-HR |
2/10/2015, 03:50 PM |
Q3 2014 |
120 |
$569M |
+$55.6M |
-$33.9M |
+$21.7M |
AAL, C, ESV, MS, DHI
|
13F-HR |
11/5/2014, 03:10 PM |
Q2 2014 |
118 |
$583M |
+$50.6M |
-$84.6M |
-$34M |
AAL, ESV, C, DHI, MS
|
13F-HR |
8/12/2014, 04:19 PM |
Q1 2014 |
117 |
$600M |
+$116M |
-$113M |
+$3.22M |
AAL, ESV, C, MS, DHI
|
13F-HR |
5/6/2014, 01:17 PM |
Q4 2013 |
114 |
$587M |
$0 |
$0 |
|
AAL, C, ESV, MS, INTC
|
13F-HR |
2/13/2014, 03:12 PM |